"Minimizing Morbidity and Maximizing ... - Advanced Prostate...

Advanced Prostate Cancer

21,056 members26,262 posts

"Minimizing Morbidity and Maximizing Outcomes w/ ADT by Laurence Klotz, MD Aug 2018"

SuppWife profile image
10 Replies

Here is more discussion of Intermittent ADT and Firmagon vs Lupron others might find interesting.

grandroundsinurology.com/mi...

I'll say on the front end it involves discussion of mouse studies which I know is controversial, but hopefully there is some meaningful data gleaned from mouse studies or they'd stop doing them, wouldn't they?

Anyway, I found this information very interesting.

Here is one nugget from the piece:

"While Dr. Klotz thought this analysis would disprove Morote’s conclusion, in actuality, the results of the analysis vindicated Morote’s observation that that lower nadir testosterone in the first year of ADT correlates with a low time to CRPC and improved cause-specific survival."

Written by
SuppWife profile image
SuppWife
To view profiles and participate in discussions please or .
Read more about...
10 Replies
Tall_Allen profile image
Tall_Allen

The studies showing that achieving lower levels of testosterone with ADT results in longer survival and delayed progression were clinical studies, not a mouse study.

ncbi.nlm.nih.gov/pmc/articl...

SuppWife profile image
SuppWife in reply to Tall_Allen

Yes, right. Thanks, TA. I didn't mean to be confusing with that disclaimer.

The reference to the pre-clinical mouse model was in the section about degarelix vs an LHRH agonist and CV events.

marnieg46 profile image
marnieg46 in reply to Tall_Allen

I know this tread is about T but although I can't quite recall the details but in relation to a quick PSA non detectable rate after commencing hormones wasn't there a study done in China that said those in this category had shorter survival time??

Tall_Allen profile image
Tall_Allen in reply to marnieg46

The point was that a quick decline to a high nadir had shorter survival. When the nadir was low, there was longer survival.

marnieg46 profile image
marnieg46 in reply to Tall_Allen

Can you explain a bit more please...what's a high nadir as opposed to a low nadir?

Tall_Allen profile image
Tall_Allen in reply to marnieg46

A high nadir would be a lowest PSA of, say, 20. A low nadir would be a lowest PSA of, say, <0.1

ncbi.nlm.nih.gov/pmc/articl...

journals.lww.com/md-journal...

Jscjac profile image
Jscjac

Thanks for sharing !

SuppWife profile image
SuppWife in reply to Jscjac

😘

cigafred profile image
cigafred

Many thanks for this reference to a great, IMHO, video. Compact/full of info, I recommend to anyone on ADT.

marnieg46 profile image
marnieg46

Thank you for positing this link. I found the information very helpful.

You may also like...

Choose Capivasertib or 177Lu-PSMA-617 clinical trial or stick with ADT + radiation?

either Capivasertib + ADT or placebo + ADT. (3) PSMAddition: Enroll in study, get screened for PSMA

Post ADT Testosterone replacement therapy

I am interested if anyone has undergone testosterone replacement after ADT. Some new studies have...

How long to Castrate Resistance: ADT+/- ARSI

Further discussion on details of EMBARK study on another HU forum bears restating here (IMO). For...

Any Data or MO Advice Regarding Dutasteride / Finasteride At Very Early Biochemical Recurrence?

Mortality (PCSM). This study, although it is combined with biculutamide, is interesting....

Dr. John Campbell on Vitamin D and Prostate Cancer.

video from Dr. John Campbell discusses a (in his opinion good) meta-analysis of Vitamin D and...